|
Originally published In Press as doi:10.1074/jbc.M106227200 on October 15, 2001
J. Biol. Chem., Vol. 276, Issue 51, 48398-48403, December 21, 2001
Exchange of the Actin-bound Nucleotide in Intact Arterial Smooth
Muscle*
Michael
Bárány §,
John T.
Barron¶,
Liping
Gu¶, and
Kate
Bárány
From the Department of Biochemistry and Molecular
Biology, and Department of Physiology and Biophysics, University
of Illinois College of Medicine, Chicago, Illinois 60612, the
¶ Section of Cardiology, Rush Medical College, Department of
Medicine, Chicago, Illinois 60612
Received for publication, July 5, 2001, and in revised form, September 19, 2001
 |
ABSTRACT |
The actin-bound ADP was separated from
cytoplasmic nucleotides by treatment of intact arterial smooth muscle
with 50% ethanol. In 32P-labeled smooth muscle the
actin-bound ADP and phosphate readily exchanged with the cytoplasmic
[ , -32P]ATP; the specific radioactivity of
actin-bound ADP was equal to that of the -phosphate of cytoplasmic
ATP and the specific radioactivity of actin-bound phosphate was equal
to that of the -phosphate of cytoplasmic ATP. In contrast, the
exchange of the actin-bound ADP in skeletal muscle was very slow. The
presence of cytoplasmic ATP was required for the exchange of the
actin-bound ADP and phosphate; if ATP synthesis was inhibited the
exchange was also inhibited. The extent of exchange was reduced in
muscles contracted by histamine or K+, as compared with
resting muscles. The exchange was also shown in other mammalian smooth
muscles, uterus, urinary bladder, and stomach. The data indicate a
dynamic state of actin in smooth muscle. The data also suggest that
polymerization-depolymerization of actin is part of the
contraction-relaxation cycle of smooth muscle.
 |
INTRODUCTION |
Straub (1) discovered actin as a contractile protein of skeletal
muscle. He noted that actin exists in two forms (2): monomer or
globular (G) form and polymer or fibrous (F) form. The G F
transformation or polymerization of actin was catalyzed by the cations
of muscle, at physiological concentration. The idea that G F
transformation of actin plays a functional role in muscle was further
supported by the discovery of Straub and Feuer (3), that G-actin
contains bound ATP (G-ATP) and F-actin contains bound ADP (F-ADP), and
that during the G F transformation of actin ATP is hydrolyzed to
ADP and Pi. However, in subsequent years no evidence was
obtained for a G-ATP F-ADP + Pi transformation in
skeletal muscles of live animals (4).
Recently, Mehta and Gunst (5) and Jones et al. (6) reported
the presence of G-actin in smooth muscle, based on the method of DNase
I inhibition and phalloidin staining, respectively. We attempted to get
direct evidence for the existence of G-actin in smooth muscle. It is
known that in vitro the bound ATP of G-actin exchanges with
labeled ATP in the medium (7-9), whereas the bound ADP of F-actin does
not exchange with either labeled ATP or ADP (7). When applying this
information to intact muscle, one has to consider that in the ionic
milieu of muscle G-actin is transformed into F-actin. Therefore, to
detect a postulated G-actin intermediate the label on the G-actin must
survive the hydrolysis of the bound-ATP coupled to the polymerization
of actin. ATP double labeled with 32P in both the - and
-positions meets this requirement,
|
(Eq. 1)
|
|
(Eq. 2)
|
These equations form the rationale of our work, which reveals a
rapid exchange of the G-actin bound-ATP in intact smooth muscle. Such
an exchange is very slow in skeletal muscle.
 |
EXPERIMENTAL PROCEDURES |
32P Labeling of Arterial Smooth Muscles--
Porcine
carotid arteries were obtained from the local slaughterhouse from
freshly killed pigs. The arteries were transported in ice-cold
physiological salt solution
(PSS),1 containing in
mM: 130 NaCl, 4.7 KCl, 1.2 MgSO4, 2.5 CaCl2, 0.03 CaEDTA, 14.9 NaHCO3, and 5.5 glucose, into the laboratory, cleaned, mounted in special chambers, and
resting tension adjusted (10). The arterial muscles were regenerated by
incubation in 70 ml of PSS, at 37 °C under 95% O2 and
5% CO2 for 2 h. The muscles were ~4.5 cm long,
0.4-0.5 cm wide, and their wet weight was 0.4-0.5 g. At the end of
the incubation, carrier-free inorganic
[32P]orthophosphate (32Pi),
0.5-1.0 mCi, was added to the bath (containing 2 muscles) and
32P labeling of the muscles was continued until the
required time. 32Pi was removed from the
extracellular space of the muscle by quick washings with PSS 15 times,
each washing with 70 ml of PSS. Then the muscle was blotted gently, cut
in the middle, one half was frozen in liquid nitrogen while the other
half was dropped into 50% ethanol of 0 °C. Smooth muscles
from pregnant uteri (rat and pig), urinary bladder (rabbit and pig),
and stomach (rat and pig) were prepared as described (11) and labeled
with 32Pi by the same procedure as used for the
arterial smooth muscle.
32P Labeling of Contracted Muscles--
After the
2-h recovery incubation, the PSS was exchanged for 70 ml of contracting
solution containing either 0.1 mM histamine or a
K+-stimulating solution (in mM: 35 NaCl, 100 KCl, 1.2 MgSO4, 2.5 CaCl2, 0.03 CaEDTA, 14.9 NaHCO3, and 5.5 glucose), and the muscle was allowed to
develop tension for 10 min. Then the bath was exchanged for
32Pi containing contracting solution and
32P labeling was allowed to proceed for 20 min
(cf. Fig. 5). The muscles were washed with 70 ml of
contracting solution 15 times, then cut and fixed in liquid nitrogen or
50% ethanol solution.
Workup of the Muscles--
The frozen muscle was
pulverized (10) and the powder from 4 half-muscles was extracted with
25 ml of 1.5% PCA in an ice bath for 2 min. After a brief high-speed
centrifugation, 0.5-ml aliquots, in duplicate, were taken from the
supernatant for determination of the specific radioactivity of
phosphocreatine (PCr) (12), whereas the remainder of the extract was
poured into an equivalent 10.0 N KOH solution to neutralize
it to pH 7.5-8.0. After overnight standing in ice, the perchlorate
precipitate was removed by centrifugation; the supernatant was
concentrated by the SpeedVac and used for Dowex-1 chromatography.
In the ethanol procedure, each 4 half-muscle was extracted
with 40 ml of 50% ethanol in ice overnight. The next morning the muscles were cut with scissors, each half into 3 pieces, and extracted four more times, each extraction with 40 ml of 50% ethanol in ice bath
with stirring for 1 h. The absorbance and radioactivity of each
extract was followed; after the five extractions the absorbance and the
radioactivity were essentially zero. Subsequently, the 4 half-muscle
residues were extracted twice, with 25 ml of 1.5% PCA each time, in
ice bath for 1 h. The absorbance and the radioactivity of each
extract were recorded. The first PCA extract was neutralized with 10 N KOH solution and prepared for Dowex-1 chromatography, as
described before.
Dowex-1 Chromatography--
The resin, AG-1 X8 200-400 mesh
(Bio-Rad) in the chloride form, was recycled twice, with 1.0 N NaOH and 1.0 N HCl, so that no UV
absorbing material was eluted from the washed resin. The sample was
dissolved in 1 ml of cold distilled water and clarified by high-speed
centrifugation. The sample, containing 10-15 A260 units,
was loaded slowly onto the column (5.5 × 1 cm), and eluted stepwise with 40 ml of 0.01 N HCl (elutes nucleosides, PCr,
AMP, and other nucleotide monophosphates), 55 ml of 0.025 N
HCl (elutes inorganic phosphate, ADP, and other nucleotide
diphosphates), and 45 ml of 0.12 N HCl (elutes ATP and
other nucleotide triphosphates) (modified from Ref. 13). The flow rate
was 0.75 ml per min, 3.0-ml fractions were collected and the absorbance
was recorded at 260 and 280 nm. Since in the muscle adenine nucleotides
are predominant, the column actually separates AMP, ADP, ATP, and Pi (Fig. 1). In addition to
these compounds, the column also separates PCr.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 1.
Dowex-1 chromatography of perchloric acid
extract of arterial smooth muscle. The muscles were incubated with
32Pi for 30 min. About 12 A260 units were applied onto the column. The
line with triangles indicates the
"absorbance" and the line with squares
indicates the "counts per ml." Peak assignments: Fractions 5-7,
PCr; 12-14, AMP; 16-18, Pi; 22-27, ADP; 34-41, ATP.
These assignments were established by chromatography of the respective
pure compounds.
|
|
Determination of Muscle Weight--
After the last extraction,
the muscle residue in 1.5% PCA was stirred with 20 ml of 0.1 N NaOH at room temperature for a day. By this procedure,
all muscle proteins are solubilized with the exception of connective
tissue proteins, mainly collagen (14). The noncollageneous proteins in
the supernatant were quantified by the modified biuret procedure (15)
and converted in terms of gram muscle using the factor of 105.11 mg of
protein/1 g wet weight of arterial muscle. This factor was determined
by extracting known weight of arteries with 0.1 N NaOH
under the same conditions.
Pathways for the Incorporation of 32Pi
into ATP--
The 32Pi, added into the bath of
the muscle, permeates into the intracellular water and condenses with
ADP (produced by the basal metabolism), to synthesize
[ -32P]ATP,
|
(Eq. 3)
|
ADP is also produced through the creatine kinase catalyzed
reaction,
|
(Eq. 4)
|
This reaction is very fast and under all conditions the measured
specific radioactivity of [ -32P]ATP was equal to that
of [32P]PCr.
The ATP labeled at the -position is also labeled at the
-position, through the reaction catalyzed by the adenylate
kinase,
|
(Eq. 5)
|
|
(Eq. 6)
|
and through the regular ATP synthesis,
|
(Eq. 7)
|
Labeling of ATP both at the - and -positions is somewhat
slower than labeling at the -position alone. We found complete double labeling after 2 h of incubation of the muscle with
32Pi. Double labeling of ATP was evidenced by
the ratio of 2.0 for the specific radioactivity of
[ , -32P]ATP over the specific radioactivity of
[32P]PCr.
Under the conditions used here, the labeling of the -phosphate of
ATP was very slow. We have found 5-8% labeling in muscles incubated
with 32Pi at 37 °C for 5 h. Labeling of
-phosphate of ATP was evidenced by isolating [32P] AMP
with the Dowex-1 chromatography.
Determination of the Exchange of the Actin-bound
ADP--
Because in the intact muscle actin appears in the F-form with
ADP as its bound nucleotide, the specific radioactivity of the -phosphate of the cytoplasmic ATP is the reference for the exchange of the actin-bound ADP. Since shorter incubation of arterial muscle with 32Pi labels only the - and
-phosphates of ATP, the specific activity of the -phosphate of
the cytoplasmic ATP can be calculated from the specific activity of the
double labeled ATP minus the specific radioactivity of
[32P]PCr, namely the specific radioactivity of
[32P]PCr equals that of the -phosphate of ATP (12).
Thus,
|
(Eq. 8)
|
and the exchange of the actin-bound ADP is expressed as,
|
(Eq. 9)
|
The specific radioactivity of ATP and ADP was calculated from
the counts/min values of the top five fractions of their peaks in the
Dowex-1 chromatograms (cf. Figs. 1 and 3) and the absorbance of these fractions at 260 nm, using a molar absorption coefficient of
14.2 × 103 for adenine nucleotides at acidic pH
(16).
As will be shown, the actin-bound phosphate also exchanges and the
specific radioactivity of [32P]PCr is the reference for
this exchange. Thus, the exchange of the actin bound
[32Pi] is expressed as,
|
(Eq. 10)
|
The specific radioactivity of actin-bound Pi was
calculated from the counts/min values of the top three fractions of its peaks in the Dowex-1 chromatograms (cf. Fig. 3) and the
absorbance of the phosphomolybdate complex at 720 nm, determined
according to Rockstein and Herron (17).
Actin--
Actin was prepared from rabbit skeletal muscle (15),
polymerized with 0.1 M NaCl, and purified by
ultracentrifugation at 105,000 × g for 3 h
(modified from Ref. 18). The F-actin pellet was rinsed with distilled
water twice, to remove salts, and dissolved by a Teflon-glass
homogenizer in 0.4 mM ATP, pH 7.5, 10-12 mg of protein/ml,
0 °C. (By measuring the protein concentration of the actin solution
before ultracentrifugation and of the supernatant after
ultracentrifugation the protein content of the F-actin pellet could be
estimated.) Upon prolonged homogenization (50-70 strokes) the actin
was completely depolymerized and when centrifuged at 144,000 × g for 1 h only a small sediment (presumably F-actin) appeared. When the concentrated G-actin was treated with 20 mg of AG
1-X8 200-400 mesh resin per ml of actin solution, 4 °C, for 5 min
to remove unbound ATP, the G-actin polymerized. For this reason, no
resin treatment was performed. The G-actin solution was divided into
two parts, 1/10th volume of 1.0 M NaCl and 0.01 M MgCl2 solution was added to one part to form
F-actin, while the other part remained G-actin. After the preparation
of G-actin and F-actin, the experiments started immediately and all
treatments were carried out in an ice bath.
Miscellaneous--
Data were expressed as mean ± S.E.
Radioactivity was measured by liquid scintillation counting.
32Pi was obtained from ICN.
 |
RESULTS |
Separation of Actin-bound Nucleotides from Cytoplasmic Nucleotides
in Intact Smooth Muscle--
Verhoeven et al. (19)
separated the free and actin-bound nucleotides of platelets in 56%
ethanol containing 6.7 mM EDTA. Applying their procedure to
arterial smooth muscle, we have found no need for EDTA and reduced the
ethanol concentration to 50% to increase the solubility of nucleotides
and inorganic salts of muscle in the aqueous ethanol.
Fig. 2 shows the extraction of
nucleotides and radioactivity from 32P-labeled arterial
muscles upon treatments with 50% ethanol and subsequently with 1.5%
PCA. In the first extract 46.1% of the total nucleotide absorbance at
260 nm and 58.8% of the total counts were solubilized. In the second
extract these numbers decreased to 10.5 and 12.2%, respectively, and
in the third extract they decreased to 3.0 and 3.6%, respectively. The
remaining percentage absorbance was 0.5 in the fourth extract and zero
in the fifth and sixth extracts; small amounts of counts were
observable in these extracts, approaching the zero level. At this
stage, the solvent was changed to 1.5% PCA; this resulted in the
appearance of 30% of the total absorbance and 19.2% of the total
counts, whereas the second PCA extraction yielded 9.9% of the
absorbance and 4% of the counts. Accordingly, PCA extracted from the
ethanol-washed muscle about 40% of the total absorbance at 260 nm and
about 23% of the total counts. As will be described, this absorbance
and counts belong to the actin-bound nucleotide and phosphate in the muscle. In comparing the percentage absorbance with the percentage counts extracted, it should be noted that all the absorbance refers to
nucleotides, but the counts include compounds, which do not absorb in
the U.V., e.g. the intermediates of glycolysis.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 2.
Extraction of nucleotides and radioactivity
from 32P-labeled arterial muscles. Four arterial
muscles were labeled with 32Pi, by incubation
at 37 °C for 1 h. Each muscle was then extracted with 50%
ethanol 6 times, each extraction with 10 ml of ethanol in ice bath. The
first extraction was for 12 h, and all subsequent extractions were
for 2 h. At the end of each period, the ethanol was removed from
the muscle and the extract was analyzed for absorbance at 260 nm and
radioactivity. Then each muscle was extracted with 10 ml of 1.5% PCA
twice in an ice bath, each for 1 h, and analyzed for absorbance
and radioactivity. The value for 100% absorbance was 33.94 A260 per g muscle and 100% counts were
3.70 × 107 cpm/g muscle.
|
|
The Stability of Pure Actin in 50% Ethanol--
Straub (1)
observed that actin could be precipitated with ethanol without loss of
activity. In our experiments, 50% ethanol did not precipitate G-actin
or F-actin, and after the ethanol was removed G-actin solutions
retained their ability to polymerize and F-actin solutions remained
viscous. In our attempt to measure the effect of 50% ethanol on the
bound nucleotide content of actin, we rediscovered (7) that ATP does
not permeate through standard dialysis membranes. Subsequently, the
following protocol was used for studying the stability of the
actin-bound nucleotide in 50% ethanol.
To purified G-actin or F-actin, 10.5-11.5 mg/ml, in an ice bath, equal
volume of cold absolute ethanol was added in small increments. The
solutions were kept in the ice bath for 1 day. Control G-actin and
F-actin solutions were prepared by adding an equal volume of cold
distilled water to the actin solutions. Aliquots, 1 ml, were removed at
time intervals of 3, 6, 12, and 24 h from the ethanol treated and
control actin solutions and dialyzed against 15 liters of distilled
water (G-actin) or 15 liters of 0.1 M NaCl and 1 mM MgCl2 solution (F-actin) in the cold room
for 1 h. After the dialysis, the ethanol content of the treated
samples was measured with alcohol dehydrogenase (Sigma ethanol
diagnostic test) and it was reduced from the original 50% ethanol to
less than 0.5% ethanol. To quantify their nucleotide content, the
G-actin solutions were polymerized by the addition of 1/10th volume of
1.0 M NaCl and 0.01 M MgCl2
solution and subjected to ultracentrifugation, along with the dialyzed
F-actin samples, at 144,000 × g for 1 h.
Virtually all the actin protein, 91-97%, was sedimented under these
conditions. The supernatant was removed and the pellet was rinsed with
distilled water; the pellet was dissolved by homogenization in 3.0 ml
of 0.2 N NaOH, then the proteins precipitated with excess
perchloric acid. After centrifugation, the absorbance of the
supernatant was measured at 260 and 280 nm, the pellet was dissolved in
1.0 ml of 1.0 N NaOH and its protein content measured by
the biuret method. The bound nucleotide content of the 50%
ethanol-treated G-actin or F-actin did not differ from that of the
untreated G-actin or F-actin. Furthermore, the bound nucleotide content
did not decrease as a function of time during the 1-day incubation. The
bound nucleotide content was in the range of 0.8-0.9 µmol of
nucleotide per 42 mg of protein (n = 3). These results
show that purified G-actin and F-actin retained their bound nucleotide
during 1-day treatment with 50% ethanol.
Analysis of the Actin-bound Nucleotide--
Fig.
3 shows the Dowex-1 chromatography
profile of actin-bound nucleotide, isolated from arterial muscle by
ethanol treatment. There are two nucleotides present, ADP and ATP with
an approximate ratio of 7 to 1. There are three radioactive peaks; the
first comes from Pi, the second from ADP, and the third
from ATP. (As described in the next paragraph, the Pi peak
represents the actin-bound phosphate.) The specific radioactivity, in
terms of cpm/µmol, was: 9.53 ± 0. 21 × 106
for Pi, 9.76 ± 0.75 × 106 for ADP,
and 20.10 ± 1.79 × 106 for ATP. The specific
radioactivity of the cytoplasmic ATP, from the same muscle, was
19.85 ± 0.63 × 106, and that of PCr was
10.01 × 106. From the last two data, using Equation 8, the specific radioactivity of -phosphate of ATP was calculated to
be 9.84 × 106 cpm/µmol. By comparing the specific
radioactivity of actin-bound ADP with that of the -phosphate of
cytoplasmic ATP, and comparing the specific radioactivity of
actin-bound ATP with that of the cytoplasmic ATP, it is evident that
the actin-bound nucleotide was completely exchanged with the
[ , -32P]ATP in the intracellular water. The data
also show that during the 2-h incubation of the muscle with
32Pi the specific radioactivity of
-phosphate of the cytoplasmic ATP reached the specific radioactivity
of its -phosphate. Furthermore, the specific radioactivity of the
actin-bound phosphate reached the specific radioactivity of PCr.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 3.
Dowex-1 chromatography of actin-bound
nucleotide. Arterial smooth muscles were incubated with
32Pi for 2 h. The 50% ethanol treatment
was used for isolation of the bound nucleotides. About 14 A260 units were applied onto the column. The
line with triangles indicates the absorbance and
the line with squares indicates the counts per
ml. Peak assignments: Fractions 16-18, Pi; 22-30, ADP;
36-40, ATP.
|
|
Actin-bound Phosphate--
The following data suggest the
existence of actin-bound phosphate. The first 50% ethanol extract of
arterial muscle (Fig. 2) is loaded with 32Pi,
due to the complete hydrolysis of cytoplasmic
[ , -32P]ATP. (This was shown by Dowex-1
chromatography.) Through the successive ethanol extractions, the
32Pi is removed from the muscle completely
(Fig. 2). However, when the residue is extracted with PCA the
32Pi reappears (Fig. 3).
In muscles incubated with 32Pi for a short
time, the specific radioactivity of the actin-bound Pi
differed greatly from that of the actin-bound ADP. For instance, with
20 min incubation the specific radioactivity of actin-bound
[32P]ADP was 1.87 × 106 cpm/µmol, the
specific radioactivity of the actin-bound
[32P]Pi was 5.01 × 106
cpm/µmol, and the specific radioactivity of [32P]PCr
was 5.79 × 106 cpm/µmol. Thus, the actin-bound
Pi resembled PCr and not actin-bound ADP. Since the
specific radioactivity of [32P]PCr equals that of
[ -32P]ATP, it appears that the
[32P]Pi is liberated from the terminal
phosphate of [ , -32P]ATP during the polymerization
of actin (Equation 2).
The concentration of the actin-bound Pi was 60-85% of
that of the actin-bound ADP. In vitro studies showed that
the actin-bound Pi dissociates slowly, whereas the
actin-bound ADP does not dissociate in practical terms (21-23). Thus,
the reduced phosphate content of actin in the muscle, relative to its
ADP content, can be explained by the slow dissociation of the phosphate
from actin during the prolonged 50% ethanol washing of the arterial muscle.
Quantification of the Actin-bound Nucleotide--
From the
absorbance of the PCA extract and the protein content of the PCA
residue, we calculated 1.11 ± 0.10 µmol of nucleotide/g of wet
muscle weight (n = 35). All this nucleotide was fully
exchanged when resting muscle was incubated with
32Pi for 45-60 min. With a molecular mass of
42,000 daltons (20), the actin content was 46.6 mg/g muscle in good
agreement with the reported actin content of carotid arteries, 48.5 mg/g (20). ADP comprised 85-88% of the bound nucleotide, while ATP
amounted to 12-15%.
Exchange of the Actin-bound Nucleotide in Resting Muscle--
Fig.
4 shows the percentage exchange as a
function of time for porcine carotid arterial smooth muscle and rat
skeletal muscle. In the case of the smooth muscle, no reasonable
measurements could be performed in the first 15 min of the
32Pi incubation. During this period the
32Pi permeates into the cytoplasm (a slow
process), followed by the synthesis of 32P-labeled ATP, and
only then can an exchange of the actin-bound ADP take place. At the
15-min incubation the exchange was 53%, raising to 81% at 20 min, and
95% at 30 min. Subsequently, the exchange remained at 100% level up
to 3 h of incubation.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 4.
Time course of the exchange of the
actin-bound ADP in smooth and skeletal muscle. Porcine carotid
artery (line with triangles) was used as smooth muscle, the
vastus muscles (line with squares) of rat were used as
skeletal muscle. After 2 h incubation with the proper PSS, the
muscles were incubated with 32Pi-labeled PSS
for time periods shown on the abscissa. The workup of the
muscles is described under "Experimental Procedures." The
percentage exchange was calculated with Equation 9.
|
|
In contrast to the rapid exchange in smooth muscle, the exchange in rat
skeletal muscles was very slow. The exchange was followed in hourly
intervals and reached about 15% after 3 h of incubation. Not
shown are results with frog leg skeletal muscles, incubated at 25 °C
(at 37 °C frog muscles denature) that also exhibited a slow
exchange. These data are in good agreement with the results of
Martonosi et al. (4) who discovered the slow exchange of the
actin-bound nucleotide in skeletal muscles of live rabbits, rats, and pigeons.
Exchange of the Actin-bound Nucleotide during Contraction--
Two
types of contracting solutions were used, 0.1 mM histamine
and 100 mM K+, both elicited maximal force.
Fig. 5 shows the experimental protocol. After adjusting the resting tension at 0 min, the PSS in the bath was
exchanged for a solution containing 0.1 mM histamine in
PSS, maximal force of the arterial muscle was reached in 10 min. The bath was exchanged for a solution containing
32Pi in 0.1 mM histamine-PSS and
32P labeling of the muscle was allowed for 20 min, then the
muscle was washed 15 times with 0.1 mM histamine/PSS for a
total time of 15 min. Note, the force remained maximal both during the
labeling and subsequent washings.

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 5.
32P labeling of contracted
arterial muscle. For explanation see the text.
"Hist" is the abbreviation of histamine.
|
|
Table I compares the percentage exchange
of actin-bound ADP and Pi, during 20 min, in 15 resting and
contracting muscles (11 were contracted with 0.1 mM
histamine and 4 were contracted with 100 mM
K+). The percentage exchange in resting muscle reached 81%
for ADP and 80% for Pi, whereas in contracting muscle the
exchange amounted to 59 and 57%, respectively. The difference in the
exchangeability, between resting and contracting muscles, is apparently
due to the interaction of actin with myosin that alters the rate of
exchange. The 22-23% decrease in the exchangeability is in agreement
with the data of Mehta and Gunst (5) which showed a 30% decrease in
the G-actin content of stimulated canine tracheal muscles
versus the unstimulated muscles.
View this table:
[in this window]
[in a new window]
|
Table I
Exchange of actin-bound ADP and Pi in resting and contracting
arterial muscles
Muscles were incubated in 70 ml of PSS, at 37 °C, for 2 h.
Resting muscles were incubated with 32Pi (0.5 mCi per
muscle) for 20 min, then quickly washed with PSS 15 times, each wash
with 70 ml of PSS. Muscles were contracted either with 70 ml of 0.1 mM histamine in PSS or 100 mM KCl in the
modified PSS for 10 min, then incubated with the contracting solution
containing 0.5 mCi of 32Pi per muscle for 20 min, and
quickly washed with 70 ml of the contracting solution 15 times. The
workup of the muscles is described under "Experimental Procedures."
The percentage exchange for ADP and Pi was calculated with
Equations 9 and 10, respectively.
|
|
The decrease in the exchangeability of the actin-bound ADP and
Pi was found to be reversible. Muscles contracted with the 100 mM K+ solution were completely relaxed by
repeated washings with PSS; the percentage exchange of both ADP and
Pi in the relaxed muscle increased to 82% from its 58%
value in the contracted muscle.
Inhibition of the Exchange--
If there is no ATP in the arterial
muscle the actin-bound ADP does not exchange. This was demonstrated: 1)
by incubating the muscles with 10 mM sodium azide and 50 µM iodoacetate in PSS at 37 °C for 2 h, and
subsequently with 32Pi in PSS for 2 h. No
ATP was found in the muscles, although they did contain
32Pi. There was no radioactivity incorporated
into the actin-bound ADP and Pi, indicating that
32Pi alone in the cytoplasm is not enough for
the exchange reaction to take place. 2) By using iodoacetamide
treatment, after 2 h incubation in PSS, the muscles were incubated
with 10 mM iodoacetamide in PSS for 90 min, followed by
incubation with 32Pi in 10 mM
iodoacetamide/PSS for 1 h. The [ , -32P]ATP
content of the muscles was virtually zero, and there was no
32P incorporation into the actin-bound ADP. 3) Substituting
glucose with 2-deoxyglucose in PSS decreased the
[ , -32P]ATP content of the muscles to 25% of the
control muscles (24) and the percentage exchange of the actin-bound ADP
was decreased to 20%. These data show that when ATP synthesis is
inhibited the exchange of the bound-ADP is also inhibited.
It should be noted, that the actin-bound ADP was hardly affected in the
poisoned muscles although the cytoplasmic ATP was degraded to AMP and
IMP. Thus, in the three cases described before the bound nucleotide
content was 0.88, 0.91, and 1.05 µmol of nucleotide/g of wet muscle
weight. This proves the idea that the bound-ADP is not available to
cytoplasmic enzymes, which participate in ATP turnover in muscle
(3).
Ca2+ Is Not Involved in the Exchange--
Arterial
muscles were incubated in Ca2+-free PSS, which contained in
addition 1.0 mM EGTA, for 2 h and then with
32Pi in Ca2+-free PSS and EGTA for
45 min. The labeled muscles were washed with Ca2+-free PSS
and EGTA 7 times and with PSS 8 times. The actin-bound ADP and
Pi were fully exchanged in such muscles, the same way as
they exchanged in control muscles treated with normal PSS for the same time.
Analysis of the Perchloric Acid Extract--
Two major nucleotide
peaks appeared on the Dowex-1 chromatography of the PCA extract from
32P-labeled arterial muscle (Fig. 1), the first
corresponded to ADP and the second to ATP. Because of the total ADP in
PCA extract of smooth muscle (or any other muscle) is essentially the
actin-bound ADP (25, 26), from results of this Dowex-1 chromatography the percentage exchange of actin-bound ADP could be calculated. Thus,
from the specific activities of cytoplasmic ATP, PCr, and actin-bound
ADP, using Equations 8 and 9, the percentage exchange of the
actin-bound ADP was found to be 94%. A similar value, 99%, was
obtained for the other half of the same muscle, which was analyzed by
the ethanol procedure.
Other Smooth Muscles--
Table II
compares the exchange of actin-bound ADP and Pi in arterial
muscle with those of muscles from rat and porcine uterus (pregnant),
from rabbit and porcine urinary bladder, and from rat and porcine
stomach. The overall data show a complete or nearly complete exchange
in each of these smooth muscles. The somewhat larger standard error for
stomach and bladder muscles reflects the difficulties in preparing pure
smooth muscle from these tissues in larger quantities.
View this table:
[in this window]
[in a new window]
|
Table II
Exchange of actin-bound ADP and Pi in various smooth muscles
Muscles were incubated in 70 ml of PSS, at 37 °C, for 2 h,
followed by incubation in 32Pi-PSS for 1 h, then
washed with 70 ml of PSS 15 times. The workup of the muscles is
described under "Experimental Procedures." The percentage exchange
for ADP and Pi was calculated with Equations 9 and 10,
respectively.
|
|
 |
DISCUSSION |
We confirm and extend the finding of Mehta and Gunst (5) and Jones
et al. (6) on the existence of G-actin in smooth muscle.
With 32P labeling we show that all actin molecules in
porcine carotid artery readily exchange their bound ADP and
Pi. Because of the tight coupling between actin-bound
nucleotide and actin polymerization (3), the observed exchange reflects
a polymerization-depolymerization-repolymerization cycle of actin.
Applying the 32P method to uterine, urinary bladder, and
stomach smooth muscles from various sources, we find a similar exchange
of the actin-bound ADP and Pi. Under the same conditions,
rat and frog skeletal muscles show only a small exchange. These data
when combined with those of Mehta and Gunst (5) and Jones et
al. (6) obtained on canine tracheal smooth muscle, suggest that
the reversible polymerization of actin is a basic property of every
smooth muscle.
The present study establishes a new procedure for the separation of
cytoplasmic nucleotides from actin-bound nucleotides at the level of
intact smooth muscle using 50% ethanol. At this ethanol concentration,
the muscle is readily permeabilized at 0 °C and thus releases all
its free organic and inorganic constituents, while actin remains in its
native state and thereby keeps its bound nucleotide. Purified G-actin
and F-actin also retain their bound nucleotide upon prolonged ethanol
treatment. On the other hand, myosin is irreversibly denatured even
with 20% ethanol in muscle extract (27), thus it seems unlikely that
at the 50% ethanol concentration used in this work any nucleotide
would have remained bound to myosin. Furthermore, smooth muscle
contains only 100 nmol of myosin heavy chain (20), as compared with
1,100 nmol of actin; therefore, myosin cannot be responsible for the exchange of 1,100 nmol of bound nucleotides, demonstrated in this study.
The results of this work confirm the generally accepted view that actin
is in the F-form in intact muscle, because liquid nitrogen frozen and
subsequently PCA extracted arterial muscle yields ADP as the
actin-bound nucleotide. The rapid equilibration of F-ADP with the
cytoplasmic ATP in smooth muscle can be explained by the
following,
|
(Eq. 11)
|
|
(Eq. 12)
|
The isolation of the G-[ , -32P]ATP intermediate
from 32Pi-labeled smooth muscle (Fig. 3)
supports this mechanism of the exchange. The scheme does not involve
the two distinct steps found in vitro during the hydrolysis
of ATP associated with actin polymerization (21), namely the F-ATP and
F-ADP·Pi intermediates. However, our data reveal the
existence of F-[ -32P]ADP.
[32Pi] intermediate in the muscle (Fig.
3).
These data indicate the dynamic state of actin in smooth muscle. They
also support the suggestion of Mehta and Gunst (5) that contractile
activation of smooth muscle is associated with enhanced polymerization
of actin, a basic requirement for force generation in muscle.
Furthermore, the data suggest that reversible polymerization of actin
is part of the contraction-relaxation cycle of smooth muscle.
Since smooth muscle contains over 1 µmol of actin per g, the
reversible polymerization of actin coupled to ATP hydrolysis, followed
by ATP resynthesis, has a considerable energy requirement. All evidence
suggests that the actin protein itself generates the energy through the
"mechanochemistry" of actin (3). Since the actin-bound nucleotide
is not available for enzymes involved in ATP turnover, the
transformation of the actin polymer to actin monomer may provide the
energy for ATP synthesis (3).
It seems likely that actin-binding proteins are controlling the actin
dynamics in smooth muscle, well established in nonmuscle cells (28,
29). The role of profilin, thymosin 4, in the control of
actin nucleotide exchange has been described in vitro (30,
31). Other actin-binding proteins, ADF/cofilin (32), the Arp2/3 complex
(33), or leiomodin and tropomodulin (34), may be regulators of actin
filament assembly in animal cells including smooth muscle (34).
Smooth muscle, unlike skeletal or cardiac muscle, contains a large
excess of actin over myosin. The physiological role of this actin
surplus is not known. Recent trends in smooth muscle research point to
a functional role of the cytoskeleton, the main component of which is
actin (35). Analysis of 32P incorporation into the
actin-bound nucleotide and phosphate in intact live muscle may help to
find the role of actin in cytoskeleton function.
 |
ACKNOWLEDGEMENT |
We thank American Meat Packing Corp., Chicago,
for the donation of porcine carotid arteries, uteri, stomachs, and
urinary bladders.
 |
FOOTNOTES |
*
This work was supported by the Edgar Folk Jr. Foundation for
Senior Physiologists.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed. Tel.: 312-996-7268;
Fax: 312-413-0364; E-mail: mbarany@uic.edu.
Published, JBC Papers in Press, October 15, 2001, DOI 10.1074/jbc.M106227200
 |
ABBREVIATIONS |
The abbreviations used are:
PSS, physiological salt solution;
PCA, perchloric acid;
PCr, phosphocreatine;
32Pi, inorganic
[32P]orthophosphate.
 |
REFERENCES |
| 1.
|
Straub, F. B.
(1942)
in
Studies from the Institute of Medical Chemistry University Szeged
(Szent-Györgyi, A., ed), Vol. II
, pp. 3-15, S. Krager, Basel
|
| 2.
|
Straub, F. B.
(1943)
in
Studies from the Institute of Medical Chemistry University Szeged
(Szent-Györgyi, A., ed), Vol. III
, pp. 23-28, S. Krager, Basel
|
| 3.
|
Straub, F. B.,
and Feuer, G.
(1950)
Biochim. Biophys. Acta
4,
455-470[CrossRef]
|
| 4.
|
Martonosi, A.,
Gouvea, M. A.,
and Gergely, J.
(1960)
J. Biol. Chem.
235,
1707-1710[Free Full Text]
|
| 5.
|
Mehta, D.,
and Gunst, S. J.
(1999)
J. Physiol.
519,
829-840[Abstract/Free Full Text]
|
| 6.
|
Jones, K. A.,
Perkins, W. J.,
Lorenz, R. R.,
Prakash, Y. S.,
Sieck, G. C.,
and Warner, D. O.
(1999)
J. Physiol.
519,
527-538[Abstract/Free Full Text]
|
| 7.
|
Martonosi, A.,
Gouvea, M. A.,
and Gergely, J.
(1960)
J. Biol. Chem.
235,
1700-1703[Free Full Text]
|
| 8.
|
Hayashi, T.,
and Tsuboi, K. K.
(1960)
Fed. Proc.
19,
256
|
| 9.
|
Strohman, R. C.,
and Samorodin, A. J.
(1962)
J. Biol. Chem.
237,
363-370[Free Full Text]
|
| 10.
|
Bárány, K.,
Ledvora, R. F.,
Mougios, V.,
and Bárány, M.
(1985)
J. Biol. Chem.
260,
7126-7130[Abstract/Free Full Text]
|
| 11.
|
Bárány, M.,
and Bárány, K.
(1993)
Biochim. Biophys. Acta
1179,
229-233[Medline]
[Order article via Infotrieve]
|
| 12.
|
Kopp, S. J.,
and Bárány, M.
(1979)
J. Biol. Chem.
254,
12007-12012[Free Full Text]
|
| 13.
|
Pullman, M. E.
(1967)
in
Methods in Enzymology, vol X, Oxidation and Phosphorylation
(Eastabrook, R. W.
, and Pullman, M. E., eds)
, pp. 57-60, Academic Press, New York
|
| 14.
|
Lilienthal, J. L., Jr.,
Zierler, K. L.,
Folk, B. P.,
Buka, R.,
and Riley, M. J.
(1950)
J. Biol. Chem.
182,
501-508[Free Full Text]
|
| 15.
|
Bárány, M.,
and Bárány, K.
(1959)
Biochim. Biophys. Acta
35,
293-309[Medline]
[Order article via Infotrieve]
|
| 16.
|
Cohn, W. E.
(1957)
in
Methods in Enzymology
(Colowick, S. P.
, and Kaplan, N. O., eds), Vol. III
, pp. 724-743, Academic Press, New York
|
| 17.
|
Rockstein, M.,
and Herron, P. W.
(1951)
Anal. Chem.
23,
1500-1501[CrossRef]
|
| 18.
|
Mommaerts, W. F. H. M.
(1951)
J. Biol. Chem.
188,
559-565[Free Full Text]
|
| 19.
|
Verhoeven, A. J. M.,
Cook, C. A.,
and Holmsen, H.
(1988)
Anal. Biochem.
174,
672-678[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Hartshorne, D. J.
(1987)
in
Physiology of the Gastrointestinal Tract, Second Edition
(Johnson, L. R., ed)
, pp. 423-482, Raven Press, New York
|
| 21.
|
Carlier, M.-F.,
and Pantaloni, D.
(1986)
Biochemistry
25,
7789-7792[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Korn, E. D.,
Carlier, M.-F.,
and Pantaloni, D.
(1987)
Science
238,
638-644[Abstract/Free Full Text]
|
| 23.
|
Carlier, M.-F.,
and Pantaloni, D.
(1988)
J. Biol. Chem.
263,
817-825[Abstract/Free Full Text]
|
| 24.
|
Barron, J. T.,
Bárány, K.,
Bárány, M.,
and Kopp, S, J.
(1989)
Biochim. Biophys. Acta
1010,
278-282[Medline]
[Order article via Infotrieve]
|
| 25.
|
Kopp, S. J.,
Barron, J. T.,
and Tow, J. P.
(1990)
Biochim. Biophys. Acta
1055,
27-35[Medline]
[Order article via Infotrieve]
|
| 26.
|
Dillon, P. P.
(1996)
in
Biochemistry of Smooth Muscle Contraction
(Bárány, M., ed)
, pp. 393-404, Academic Press, San Diego, CA
|
| 27.
|
Szent-Györgyi, A. G.
(1951)
J. Biol. Chem.
192,
361-369[Free Full Text]
|
| 28.
|
Pollard, T. D.,
Blanchoin, L.,
and Mullins, R. D.
(2000)
Annu. Rev. Biophys. Biomol. Struct.
29,
545-576[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Pantaloni, D.,
Clainche, C. L.,
and Carlier, M.-F.
(2001)
Science
292,
1502-1506[Abstract/Free Full Text]
|
| 30.
|
Goldschmidt-Clermont, P. J.,
Furman, M. I.,
Wachstock, D.,
Safer, D.,
Nachmias, V. T.,
and Pollard, T. D.
(1992)
Mol. Biol. Cell
3,
1015-1024[Abstract]
|
| 31.
|
Carlier, M.-F.,
Jean, C.,
Rieger, K. J.,
Lenfant, M.,
and Pantaloni, D.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5034-5038[Abstract/Free Full Text]
|
| 32.
|
Bamburg, J. R.
(1999)
Annu. Rev. Cell Dev. Biol.
15,
185-230[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Welch, M. D.,
DePace, A. H.,
Verma, S.,
Iwamatsu, A.,
and Mitchison, T. J.
(1997)
J. Cell Biol.
138,
375-384[Abstract/Free Full Text]
|
| 34.
|
Conley, C. A.
(2001)
Am. J. Physiol. Cell Physiol.
280,
C1645-C1656[Abstract/Free Full Text]
|
| 35.
|
Morgan, K. G.
(2001)
Am. J. Physiol. Cell Physiol.
280,
C1634-C1635[Free Full Text]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. D. Tang
p130 Crk-Associated Substrate (CAS) in Vascular Smooth Muscle
Journal of Cardiovascular Pharmacology and Therapeutics,
June 1, 2009;
14(2):
89 - 98.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-M. Liou, M. Watanabe, M. Yumoto, and S. Ishiwata
Regulatory mechanism of smooth muscle contraction studied with gelsolin-treated strips of taenia caeci in guinea pig
Am J Physiol Cell Physiol,
May 1, 2009;
296(5):
C1024 - C1033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zhao, L. Du, Y. Huang, Y. Wu, and S. J. Gunst
Actin Depolymerization Factor/Cofilin Activation Regulates Actin Polymerization and Tension Development in Canine Tracheal Smooth Muscle
J. Biol. Chem.,
December 26, 2008;
283(52):
36522 - 36531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Gunst and W. Zhang
Actin cytoskeletal dynamics in smooth muscle: a new paradigm for the regulation of smooth muscle contraction
Am J Physiol Cell Physiol,
September 1, 2008;
295(3):
C576 - C587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Tang and Y. Anfinogenova
Physiologic Properties and Regulation of the Actin Cytoskeleton in Vascular Smooth Muscle
Journal of Cardiovascular Pharmacology and Therapeutics,
June 1, 2008;
13(2):
130 - 140.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Tang
Intermediate filaments in smooth muscle
Am J Physiol Cell Physiol,
April 1, 2008;
294(4):
C869 - C878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Srinivasan, S. Forman, R. A. Quinlan, J. Ohanian, and V. Ohanian
Regulation of contractility by Hsp27 and Hic-5 in rat mesenteric small arteries
Am J Physiol Heart Circ Physiol,
February 1, 2008;
294(2):
H961 - H969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhang and S. J. Gunst
Interactions of Airway Smooth Muscle Cells with Their Tissue Matrix: Implications for Contraction
Proceedings of the ATS,
January 1, 2008;
5(1):
32 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhang, Y. Wu, C. Wu, and S. J. Gunst
Integrin-linked Kinase Regulates N-WASp-mediated Actin Polymerization and Tension Development in Tracheal Smooth Muscle
J. Biol. Chem.,
November 23, 2007;
282(47):
34568 - 34580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Anfinogenova, R. Wang, Q.-f. Li, A. M. Spinelli, and D. D. Tang
Abl Silencing Inhibits CAS-Mediated Process and Constriction in Resistance Arteries
Circ. Res.,
August 17, 2007;
101(4):
420 - 428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Wang, Q. Li, and D. D. Tang
Role of vimentin in smooth muscle force development
Am J Physiol Cell Physiol,
September 1, 2006;
291(3):
C483 - C489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhang and S. J. Gunst
Dynamic association between {alpha}-actinin and {beta}-integrin regulates contraction of canine tracheal smooth muscle
J. Physiol.,
May 1, 2006;
572(3):
659 - 676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Ohanian, K. Gatfield, and J. Ohanian
Role of the Actin Cytoskeleton in G-Protein-Coupled Receptor Activation of PYK2 and Paxillin in Vascular Smooth Muscle
Hypertension,
July 1, 2005;
46(1):
93 - 99.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Tang, W. Zhang, and S. J. Gunst
The Adapter Protein CrkII Regulates Neuronal Wiskott-Aldrich Syndrome Protein, Actin Polymerization, and Tension Development during Contractile Stimulation of Smooth Muscle
J. Biol. Chem.,
June 17, 2005;
280(24):
23380 - 23389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhang, Y. Wu, L. Du, D. D. Tang, and S. J. Gunst
Activation of the Arp2/3 complex by N-WASp is required for actin polymerization and contraction in smooth muscle
Am J Physiol Cell Physiol,
May 1, 2005;
288(5):
C1145 - C1160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Tang and S. J. Gunst
The Small GTPase Cdc42 Regulates Actin Polymerization and Tension Development during Contractile Stimulation of Smooth Muscle
J. Biol. Chem.,
December 10, 2004;
279(50):
51722 - 51728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Barany and P. P. de Tombe
Rapid exchange of actin-bound nucleotide in perfused rat heart
Am J Physiol Heart Circ Physiol,
April 1, 2004;
286(4):
H1394 - H1401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Opazo Saez, W. Zhang, Y. Wu, C. E. Turner, D. D. Tang, and S. J. Gunst
Tension development during contractile stimulation of smooth muscle requires recruitment of paxillin and vinculin to the membrane
Am J Physiol Cell Physiol,
February 1, 2004;
286(2):
C433 - C447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D Tang, C. E Turner, and S. J Gunst
Expression of non-phosphorylatable paxillin mutants in canine tracheal smooth muscle inhibits tension development
J. Physiol.,
November 15, 2003;
553(1):
21 - 35.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Tang and J. Tan
Downregulation of profilin with antisense oligodeoxynucleotides inhibits force development during stimulation of smooth muscle
Am J Physiol Heart Circ Physiol,
October 1, 2003;
285(4):
H1528 - H1536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Tang and J. Tan
Role of Crk-Associated Substrate in the Regulation of Vascular Smooth Muscle Contraction
Hypertension,
October 1, 2003;
42(4):
858 - 863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Gunst and J. J. Fredberg
The first three minutes: smooth muscle contraction, cytoskeletal events, and soft glasses
J Appl Physiol,
July 1, 2003;
95(1):
413 - 425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D Tang, M.-F. Wu, A. M Opazo Saez, and S. J Gunst
The focal adhesion protein paxillin regulates contraction in canine tracheal smooth muscle
J. Physiol.,
July 15, 2002;
542(2):
501 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|